Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.
Times cited: 82
Potential regional differences for the tolerability profiles of fluoropyrimidines.
Journal of Clinical Oncology.
Times cited: 145